nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC

The phase 4 ABOUND.70+ trial assessed the safety and efficacy of nab-paclitaxel/carboplatin continuously or with a 1-week break between cycles in elderly patients with advanced non-small cell lung cancer (NSCLC). Patients ≥70 years with locally advanced/metastatic NSCLC were randomized 1:1 to first-...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Front Oncol
Main Authors: Langer, Corey J., Kim, Edward S., Anderson, Eric C., Jotte, Robert M., Modiano, Manuel, Haggstrom, Daniel E., Socoteanu, Matei P., Smith, David A., Dakhil, Christopher, Konduri, Kartik, Berry, Tymara, Ong, Teng J., Sanford, Alexandra, Amiri, Katayoun, Goldman, Jonathan W., Weiss, Jared
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2018
Fag:
Oncology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6066531/
https://ncbi.nlm.nih.gov/pubmed/30087851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00262
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker